Nuzenio

Tradingview Ptgx

Tradingview Ptgx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Protagonist Therapeutics, Inc. Stock 12‑Month Price Target Raised to $152.14, Implies 11% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:29 GMTProtagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:22:29 GMTPTGX: Strong partnered revenues and a diversified pipeline position the company for major value creation - TradingViewTradingView · Wed, 05 Aug 2026 20:32:12 GMTPTGX: Q2 2026 net income soared to $162.8M, fueled by ICOTYDE sales and Takeda milestone payments - TradingViewTradingView · Wed, 05 Aug 2026 20:27:02 GMTProtagonist Therapeutics, Inc 2026: Revenue $213.48M, EPS $2.29— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTPTGX: Q2 2026 net income reached $162.8M, fueled by milestone and opt-out payments; cash rose to $849.5M - TradingViewTradingView · Wed, 05 Aug 2026 20:18:30 GMTPTGX Q2'26 Earnings: EPS estimate is 2.23 USD - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 23:20:29 GMTProtagonist Therapeutics, Inc. Stock 12‑Month Price Target Raised to $152.14, Implies 11% Upside - TradingView
Wed, 05 Aug 2026 21:22:29 GMTProtagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 20:32:12 GMTPTGX: Strong partnered revenues and a diversified pipeline position the company for major value creation - TradingView
Wed, 05 Aug 2026 20:27:02 GMTPTGX: Q2 2026 net income soared to $162.8M, fueled by ICOTYDE sales and Takeda milestone payments - TradingView
Wed, 05 Aug 2026 20:26:35 GMTProtagonist Therapeutics, Inc 2026: Revenue $213.48M, EPS $2.29— 10-Q Summary - TradingView
Wed, 05 Aug 2026 20:18:30 GMTPTGX: Q2 2026 net income reached $162.8M, fueled by milestone and opt-out payments; cash rose to $849.5M - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Ptgx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.